OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

Impact · against what's priced in

The adoption of OpenAI's Rosalind AI by Moderna and Novo Nordisk is a positive validation of AI in biotech, though for Moderna it is a marginal addition to an already bullish platform valuation. For Nvidia, the mentioned competitive pressure from Google and Amazon to attract AI app developers directly challenges the dominance of its software ecosystem.

NVDA−0.20: Challenges what's priced in
The price assumes

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

What matters in this story

Dow rises 1% as earnings gains and lower oil prices lift Wall Street

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

What matters in this story

Dow rises 1% as earnings gains and lower oil prices lift Wall Street

How each ticker is affected

Connected tickers

Track these names every morning.

GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud Lawsuit

SpaceX is spending more than ever on AI. Its AI business is also bringing in more than Starlink for the first time.

Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Inches Higher

Elon Musk says Tesla and SpaceX have set up committees to explore a merger

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

What matters in this story

Next reads from the same story arc

Dow rises 1% as earnings gains and lower oil prices lift Wall Street

OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

What matters in this story

Next reads from the same story arc

Dow rises 1% as earnings gains and lower oil prices lift Wall Street

How each ticker is affected

Connected tickers

Track these names every morning.

GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud Lawsuit

SpaceX is spending more than ever on AI. Its AI business is also bringing in more than Starlink for the first time.

Moderna Jumps 7% While Melanoma Vaccine Data Looms; Bristol Myers Squibb Rises 5%, Pfizer Inches Higher

Elon Musk says Tesla and SpaceX have set up committees to explore a merger